VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 637 participants.
Also called NCT04654052
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 637 participants
- Sponsor
- Registry
-
NCT04654052
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Spain
- Registry status
- Completed
Technical summary
Registry record NCT04654052. Randomized; no masking; primary purpose treatment. Start 2021-07-02 (actual); primary completion 2026-07-29 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome
- Acronym
- VERONICA
- Condition
- Acute Coronary Syndrome
- Condition
- Acute Myocardial Infarction
- Condition
- Coronary Artery Disease
- Condition
- Percutaneous Coronary Intervention
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Previous treatment
- Lead sponsor
- Fundación EPIC
Record details
- Record id
cardio:ct-nct04654052- Content hash
a7c16070e818014b974f8470b204c39a2c079dde0407bcc8cd637a6d99a84e8b